Dr. Gloria Suau - Sanchidrian, M.D
NPI: 1679658561
Total Payments
$1,143
2024 Payments
$193.10
Companies
7
Transactions
28
Payment Breakdown by Category
Food & Beverage$1,143 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,143 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $866.80 | 21 | $0 (2024) |
| Tris Pharma Inc | $158.61 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $29.27 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $25.00 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $22.00 | 1 | $0 (2024) |
| PFIZER INC. | $21.25 | 1 | $0 (2017) |
| Sage Therapeutics, Inc. | $20.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193.10 | 9 | ABBVIE INC. ($121.50) |
| 2023 | $452.02 | 11 | AbbVie Inc. ($347.37) |
| 2022 | $476.89 | 7 | ABBVIE INC. ($397.93) |
| 2017 | $21.25 | 1 | PFIZER INC. ($21.25) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| 10/23/2024 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.33 | General |
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Tris Pharma Inc | Quillivant (Drug), Dyanavel XR, Quillichew ER | Food and Beverage | In-kind items and services | $79.65 | General |
| Category: ADHD | ||||||
| 08/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neuroscience | ||||||
| 03/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $94.40 | General |
| 10/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2022 | Tris Pharma Inc | Dyanavel XR (Drug), Quillivant, Quillichew ER | Food and Beverage | In-kind items and services | $78.96 | General |
| Category: ADHD | ||||||
| 09/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Gloria Suau - Sanchidrian, M.D
Dr. Gloria Suau - Sanchidrian, M.D is a Child & Adolescent Psychiatry healthcare provider based in Rio Piedras, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679658561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gloria Suau - Sanchidrian, M.D has received a total of $1,143 in payments from pharmaceutical and medical device companies, with $193.10 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,143).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Rio Piedras, PR
- Active Since 10/26/2006
- Last Updated 08/15/2019
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1679658561
Products in Payments
- VRAYLAR (Drug) $661.87
- Quillivant (Drug) $79.65
- Dyanavel XR (Drug) $78.96
- REXULTI (Drug) $29.27
- INVEGA SUSTENNA (Drug) $25.00
- QUILLICHEW ER (Drug) $21.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.